U.S. Food & Drug Administration

Description

This enduring material activity focuses on internet pharmacies with the purpose of educating the public on the potential dangers of buying medications from unsafe online pharmacies. This activity provides guidance for consumers on how to identify which online pharmacies are safe to use, enabling them to make informed decisions, and provides tools that healthcare professionals can utilize to guide patients.

This activity features educational content from the "Q&A with FDA" Podcast Series, produced by FDA's Division of Drug Information. This podcast series addresses some of the most frequently asked questions that we've received at the FDA.

References

Locate a State-Licensed Online Pharmacy: https://www.fda.gov/drugs/besaferx-your-source-online-pharmacy-information/locate-state-licensed-online-pharmacy
How to Buy Medicines Safely From an Online Pharmacy: https://www.fda.gov/consumers/consumer-updates/how-buy-medicines-safely-online-pharmacy
BeSafeRx: Your Source for Online Pharmacy Information: https://www.fda.gov/drugs/quick-tips-buying-medicines-over-internet/besaferx-your-source-online-pharmacy-information
Safe pharmacy: https://safe.pharmacy/
Reporting Unlawful Sales of Medical Products on the Internet: https://www.accessdata.fda.gov/scripts/email/oc/buyonline/english.cfm
The Center for Safe Internet Pharmacies (CSIP): https://safemedsonline.org/

Learning Objectives

Identify some of the signs that would make an online pharmacy unsafe.
Recognize some of the red flags to look out for once an order for medications from online pharmacies arrives.
Summarize the four main things to look for in order to ensure an online pharmacy is safe.
Determine appropriate resources that may help consumers navigate safe online pharmacies.
Indicate how consumers and health care professionals can report unsafe online pharmacies to the FDA.

Target Audience
This activity is intended for physicians, pharmacists, pharmacy technicians, nurses, Certified Public Health (CPH) Professionals, and physician assistants.

Registration Information
Registration is complimentary; therefore refunds are not applicable. For information on how to register to attend this activity, please contact the Activity Coordinator(s) listed above.

Continuing Education Accreditation

In support of improving patient care, FDA Center for Drug Evaluation and Research is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

This activity was planned by and for the healthcare team, and learners will receive 0.5 Interprofessional Continuing Education (IPCE) credit(s) for learning and change.

CME

FDA Center for Drug Evaluation and Research designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)^™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CPE

This knowledge-based activity has been assigned ACPE Universal Activity Number JA0002895-0000-24-026-H05-P, and ACPE Universal Activity Number JA0002895-0000-24-026-H05-T for 0.50 contact hour(s).

CNE

FDA Center for Drug Evaluation and Research designates this activity for 0.50 contact hour(s).

AAPA

This activity is designated for 0.50 AAPA Category 1 CME credits. FDA Center for Drug Evaluation and Research has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria.Approval is valid until January 15, 2027. PAs should only claim credit commensurate with the extent of their participation.

CPH

Up to 0.50 CPH Recertification Credits may be earned at this event.

Requirements for Receiving CE Credit

All learners claiming credit must attest to their attendance and complete all required activity evaluation(s) in the FDA CE Portal (ceportal.fda.gov) within 14 days after an activity ends. Upon completion, learners may view/print statement of credit.

Attention NABP Pharmacists and Pharmacy Technicians: The FDA CE Team will report your credit to the National Association of Boards of Pharmacy (NABP) provided you add your NABP ID and date of birth to your profile in the FDA CE Portal. The only official Statement of Credit is the one you pull from CPE Monitor. If you do not see your credit reflected on CPE Monitor* after 45 days of attestation, please contact FDACETeam@fda.hhs.gov. *CPE Monitor sets a strict 60-day limit on uploading credits.

Disclosure

Faculty

Deshields, Lysette, PharmD, JD, Regulatory Officer, FDA/CDER/OC/ODSIR - nothing to disclose
Roach, Sara, PharmD, Pharmacist, FDA - I have the following relationship(s): Walgreens Pharmacy - Employee

Planning Committee

Cao, Christian, MPAS, PA-C, Cross-Discipline Safety Advisor, FDA/CDER/OSE/OPE - nothing to disclose
De Fronzo, Kimberly, RPh, MS, MBA, Consumer Safety Officer, FDA/CDER/OCOMM/DDI - nothing to disclose
Kapoor, Rama, MD, Senior Physician, FDA - nothing to disclose
Paraoan, Dianne, MPH, BSN, RN, Associate Director for Regulatory Affairs, FDA/ CDER/ OMP - nothing to disclose

CE Consultation and Accreditation Team

Bueide, Rachel E., MPhil, Training Specialist, FDA/CDER/OEP/DLOD - nothing to disclose
Bryant, Traci, M.A.T., Lead Training Specialist, FDA/CDER/OEP/DLOD - nothing to disclose
Wood, Sara, Accreditation Program Administrator, CECAT, FDA/CDER/OEP/DLOD - nothing to disclose

Any relationship shown above in italics has been divested within the last 24 months and is therefore considered mitigated.
All relevant financial relationships have been mitigated.

Requirements for Certificate of Completion (Non CE)
Must attend 100% of the activity.

Initial Release Date
January 16, 2024

Expiration Date
January 15, 2027

The .gov means it's official.

The site is secure.